Nektar Therapeutics (NKTR)

Nektar Therapeutics Revenue

Nektar Therapeutics had revenue of $10.46M in the quarter ending March 31, 2025, a decrease of -51.66%. This brings the company's revenue in the last twelve months to $87.25M, down -3.24% year-over-year. In the year 2024, Nektar Therapeutics had annual revenue of $98.43M with 9.22% growth.

• Revenue (ttm): $87.25M
• Revenue Growth: -3.24%
• P/S Ratio: 3.68
• Revenue / Employee: $1,430,295
• Employees: 61
• Market Cap: 397.23M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	98.43M	8.31M	9.22%
Dec 31, 2023	90.12M	-1.93M	-2.10%
Dec 31, 2022	92.06M	-9.85M	-9.67%
Dec 31, 2021	101.91M	-51.01M	-33.36%
Dec 31, 2020	152.92M	38.30M	33.41%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.